APA (7th ed.) Citation

Camp, D., Caputo, M., Echevarria, F. M., & Achenbach, C. J. (2024). Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19. BMC Infectious Diseases, 24(1), 1. https://doi.org/10.1186/s12879-024-09842-8

Chicago Style (17th ed.) Citation

Camp, Daniel, Matthew Caputo, Fabiola Moreno Echevarria, and Chad J. Achenbach. "Clinical Rebound After Treatment with Nirmatrelvir/ritonavir in COVID-19." BMC Infectious Diseases 24, no. 1 (2024): 1. https://doi.org/10.1186/s12879-024-09842-8.

MLA (9th ed.) Citation

Camp, Daniel, et al. "Clinical Rebound After Treatment with Nirmatrelvir/ritonavir in COVID-19." BMC Infectious Diseases, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12879-024-09842-8.